Strategic application of radiotherapy for hepatocellular carcinoma

키워드

참고문헌 (112)

1. Benson AB, 3rd, "NCCN Guidelines Insights: Hepatobiliary Cancers, Version 1.2017", J Natl Compr Canc Netw, 15, pp.563~573 (2017)[DOI]
2. 한국 간 암 스터디그룹, "2014 KLCSG-NCC Korea Practice Guideline for the Management of Hepatocellular Carcinoma", Gut and Liver, 9(3), pp.267~317 (2015), 거트앤리버 소화기연관학회협의회
3. Louis C, "Stereotactic radiotherapy of hepatocellular carcinoma: preliminary results", Technol Cancer Res Treat, 9, pp.479~487 (2010)[DOI]
4. Huang WY, "Stereotactic body radiation therapy in recurrent hepatocellular carcinoma", Int J Radiat Oncol Biol Phys, 84, pp.355~361 (2012)[DOI]
5. Goyal K, "Cyberknife stereotactic body radiation therapy for nonresectable tumors of the liver: preliminary results", HPB Surg, 2010 (2010)
6. Que J, "Clinical outcomes and prognostic factors of cyberknife stereotactic body radiation therapy for unresectable hepatocellular carcinoma", BMC Cancer, 16, pp.451~ (2016)[DOI]
7. Liang P, "Effect of CyberKnife stereotactic body radiation therapy for hepatocellular carcinoma on hepatic toxicity", Onco Targets Ther, 9, pp.7169~7175 (2016)[DOI]
8. Herfarth KK, "Stereotactic single-dose radiation therapy of liver tumors: results of a phase I", II trial, 2001, pp.19, 164~170
9. Tse RV, "Phase I study of individualized stereotactic body radiotherapy for hepatocellular carcinoma and intrahepatic cholangiocarcinoma", J Clin Oncol, 26, pp.657~664 (2008)[DOI]
10. Wulf J, "Stereotactic radiotherapy of primary liver cancer and hepatic metastases", Acta Oncol, 45, pp.838~847 (2006)[DOI]
11. Goodman KA, "Dose-escalation study of single-fraction stereotactic body radiotherapy for liver malignancies", Int J Radiat Oncol Biol Phys, 78, pp.486~493 (2010)[DOI]
12. Cardenes HR, "Phase I feasibility trial of stereotactic body radiation therapy for primary hepatocellular carcinoma", Clin Transl Oncol, 12, pp.218~225 (2010)[DOI]
13. Andolino DL, "Stereotactic body radiotherapy for primary hepatocellular carcinoma", Int J Radiat Oncol Biol Phys, 81, pp.e447~e453 (2011)[DOI]
14. Price TR, "Evaluation of response after stereotactic body radiotherapy for hepatocellular carcinoma", Cancer, 118, pp.3191~3198 (2012)[DOI]
15. Kang JK, "Stereotactic body radiation therapy for inoperable hepatocellular carcinoma as a local salvage treatment after incomplete transarterial chemoembolization", Cancer, 118, pp.5424~5431 (2012)[DOI]
16. Bujold A, "Sequential phase I and II trials of stereotactic body radiotherapy for locally advanced hepatocellular carcinoma", J Clin Oncol, 31, pp.1631~1639 (2013)[DOI]
17. Kim JW, "Phase I dose escalation study of helical intensity-modulated radiotherapy-based stereotactic body radiotherapy for hepatocellular carcinoma", Oncotarget, 7, pp.40756~40766 (2016)
18. Choi BO, "Fractionated stereotactic radiotherapy in patients with primary hepatocellular carcinoma", Jpn J Clin Oncol, 36, pp.154~158 (2006)[DOI]
19. Choi BO, "Stereotactic body radiation therapy with or without transarterial chemoembolization for patients with primary hepatocellular carcinoma: preliminary analysis", BMC Cancer, 8, pp.351~ (2008)[DOI]
20. Kwon JH, "Longterm effect of stereotactic body radiation therapy for primary hepatocellular carcinoma ineligible for local ablation therapy or surgical resection. Stereotactic radiotherapy for liver cancer", BMC Cancer, 10, pp.475~ (2010)[DOI]
21. Seo YS, "Preliminary result of stereotactic body radiotherapy as a local salvage treatment for inoperable hepatocellular carcinoma", J Surg Oncol, 102, pp.209~214 (2010)[DOI]
22. Honda Y, "Stereotactic body radiation therapy combined with transcatheter arterial chemoembolization for small hepatocellular carcinoma", J Gastroenterol Hepatol, 28, pp.530~536 (2013)[DOI]
23. Xi M, "Effectiveness of stereotactic body radiotherapy for hepatocellular carcinoma with portal vein and", or inferior vena cava tumor thrombosis, 2013, pp.8, e63864~
24. Jang WI, "High-dose stereotactic body radiotherapy correlates increased local control and overall survival in patients with inoperable hepatocellular carcinoma", Radiat Oncol, 8, pp.250~ (2013)[DOI]
25. Sanuki N, "Stereotactic body radiotherapy for small hepatocellular carcinoma: a retrospective outcome analysis in 185 patients", Acta Oncol, 53, pp.399~404 (2014)[DOI]
26. Culleton S, "Outcomes following definitive stereotactic body radiotherapy for patients with Child-Pugh B or C hepatocellular carcinoma", Radiother Oncol, 111, pp.412~417 (2014)[DOI]
27. 배선현, "Feasibility and Efficacy of Stereotactic Ablative Radiotherapy for Barcelona Clinic Liver Cancer-C Stage Hepatocellular Carcinoma", Journal of Korean Medical Science, 28(2), pp.213~219 (2013), 대한의학회
28. Que JY, "The efficacy of stereotactic body radiation therapy on huge hepatocellular carcinoma unsuitable for other local modalities", Radiat Oncol, 9, pp.120~ (2014)[DOI]
29. Zhong NB, "Stereotactic body radiotherapy combined with transarterial chemoembolization for huge (<TEX>$\geq$<", TEX>10 cm) hepatocellular carcinomas: a clinical study, 2014, pp.2, 839~844
30. Wahl DR, "Outcomes After Stereotactic Body Radiotherapy or Radiofrequency Ablation for Hepatocellular Carcinoma", J Clin Oncol, 34, pp.452~459 (2016)
31. O'Connor JK, "Long-term outcomes of stereotactic body radiation therapy in the treatment of hepatocellular cancer as a bridge to transplantation", Liver Transpl, 18, pp.949~954 (2012)[DOI]
32. Sapisochin G, "Stereotactic body radiotherapy vs. TACE or RFA as a bridge to transplant in patients with hepatocellular carcinoma. An intention-to-treat analysis", J Hepatol, 67, pp.92~99 (2017)[DOI]
33. Lee CS, "Surgical treatment of 109 patients with symptomatic and asymptomatic hepatocellular carcinoma", Surgery, 99, pp.481~490 (1986)
34. Trevisani F, "Randomized control trials on chemoembolization for hepatocellular carcinoma: is there room for new studies?", J Clin Gastroenterol, 32, pp.383~389 (2001)[DOI]
35. Geschwind JF, "Chemoembolization of hepatocellular carcinoma: results of a metaanalysis", Am J Clin Oncol, 26, pp.344~349 (2003)
36. Zeng ZC, "A comparison of chemoembolization combination with and without radiotherapy for unresectable hepatocellular carcinoma", Cancer J, 10, pp.307~316 (2004)[DOI]
37. Shim SJ, "Local radiotherapy as a complement to incomplete transcatheter arterial chemoembolization in locally advanced hepatocellular carcinoma", Liver Int, 25, pp.1189~1196 (2005)[DOI]
38. 유정일, "Prognostic Index for Portal Vein Tumor Thrombosis in Patients with Hepatocellular Carcinoma Treated with Radiation Therapy", Journal of Korean Medical Science, 26(8), pp.1014~1022 (2011), 대한의학회
39. Guo WJ, "Evaluation of combined therapy with chemoembolization and irradiation for large hepatocellular carcinoma", Br J Radiol, 73, pp.1091~1097 (2000)[DOI]
40. Li B, "Study of local threedimensional conformal radiotherapy combined with transcatheter arterial chemoembolization for patients with stage III hepatocellular carcinoma", Am J Clin Oncol, 26, pp.e92~e99 (2003)
41. Oh D, "Early threedimensional conformal radiotherapy for patients with unresectable hepatocellular carcinoma after incomplete transcatheter arterial chemoembolization: a prospective evaluation of efficacy and toxicity", Am J Clin Oncol, 33, pp.370~375 (2010)[DOI]
42. Leng ZQ, "Comparison of treatment results of interventional therapy alone, radiotherapy alone, and combined interventional therapy plus radiotherapy for primary hepatic cancer", Chin J Radiat Oncol, 9, pp.99~101 (2000)
43. Zhao MH, "Three-dimensional conformal radiotherapy combined with transcatheter arterial chemoembolization for inoperable primary liver cancer", Chin J Radiat Oncol, 15, pp.39~41 (2006)
44. Koo JE, "Combination of transarterial chemoembolization and three-dimensional conformal radiotherapy for hepatocellular carcinoma with inferior vena cava tumor thrombus", Int J Radiat Oncol Biol Phys, 78, pp.180~187 (2010)[DOI]
45. Choi C, "A prospective phase 2 multicenter study for the efficacy of radiation therapy following incomplete transarterial chemoembolization in unresectable hepatocellular carcinoma", Int J Radiat Oncol Biol Phys, 90, pp.1051~1060 (2014)[DOI]
46. Cheng JC, "Local radiotherapy with or without transcatheter arterial chemoembolization for patients with unresectable hepatocellular carcinoma", Int J Radiat Oncol Biol Phys, 47, pp.435~442 (2000)[DOI]
47. Guo WJ, "Large primary liver cancer treated by chemoembolization combined with radiotherapy successfully", Hepatogastroenterology, 50, pp.519~522 (2003)
48. Li Y, "Three-dimensional conformal radiation combined with transarterial chemoembolization for unresectable primary liver cancer", Chin J Radiat Oncol, 12, pp.30~32 (2003)
49. Chen WJ, "Three-dimensional conformal radiotherapy in combination with transcatheter arterial chemoembolization in the treatment of hepatocellular carcinoma", J BUON, 19, pp.692~697 (2014)
50. Meng MB, "Transcatheter arterial chemoembolization in combination with radiotherapy for unresectable hepatocellular carcinoma: a systematic review and meta-analysis", Radiother Oncol, 92, pp.184~194 (2009)[DOI]
51. Liao M, "Transarterial chemoembolization in combination with local therapies for hepatocellular carcinoma: a meta-analysis", PLoS One, 8, pp.e68453~ (2013)[DOI]
52. Huo YR, "Transcatheter Arterial Chemoembolization Plus Radiotherapy Compared With Chemoembolization Alone for Hepatocellular Carcinoma: A Systematic Review and Meta-analysis", JAMA Oncol, 1, pp.756~765 (2015)[DOI]
53. Yamada K, "Prospective trial of combined transcatheter arterial chemoembolization and three-dimensional conformal radiotherapy for portal vein tumor thrombus in patients with unresectable hepatocellular carcinoma", Int J Radiat Oncol Biol Phys, 57, pp.113~119 (2003)[DOI]
54. Han KH, "Pilot clinical trial of localized concurrent chemoradiation therapy for locally advanced hepatocellular carcinoma with portal vein thrombosis", Cancer, 113, pp.995~1003 (2008)[DOI]
55. Shirai S, "Feasibility and efficacy of single photon emission computed tomographybased three-dimensional conformal radiotherapy for hepatocellular carcinoma 8 cm or more with portal vein tumor thrombus in combination with transcatheter arterial chemoembolization", Int J Radiat Oncol Biol Phys, 76, pp.1037~1044 (2010)[DOI]
56. Chuma M, "Efficacy of therapy for advanced hepatocellular carcinoma: intra-arterial 5-fluorouracil and subcutaneous interferon with imageguided radiation", J Gastroenterol Hepatol, 26, pp.1123~1132 (2011)[DOI]
57. Park MS, "Combination treatment of localized concurrent chemoradiation therapy and transarterial chemoembolization in locally advanced hepatocellular carcinoma with intrahepatic metastasis", Cancer Chemother Pharmacol, 71, pp.165~173 (2013)[DOI]
58. Katamura Y, "Intra-arterial 5-fluorouracil", interferon combination therapy for advanced hepatocellular carcinoma with or without three-dimensional conformal radiotherapy for portal vein tumor thrombosis, 2009, pp.44, 492~502
59. Yoon SM, "Radiotherapy plus transarterial chemoembolization for hepatocellular carcinoma invading the portal vein: long-term patient outcomes", Int J Radiat Oncol Biol Phys, 82, pp.2004~2011 (2012)[DOI]
60. Hou JZ, "Influence of tumor thrombus location on the outcome of external-beam radiation therapy in advanced hepatocellular carcinoma with macrovascular invasion", Int J Radiat Oncol Biol Phys, 84, pp.362~368 (2012)[DOI]
61. Tang QH, "Surgical resection versus conformal radiotherapy combined with TACE for resectable hepatocellular carcinoma with portal vein tumor thrombus: a comparative study", World J Surg, 37, pp.1362~1370 (2013)[DOI]
62. Cho JY, "The feasibility of combined transcatheter arterial chemoembolization and radiotherapy for advanced hepatocellular carcinoma", Liver Int, 34, pp.795~801 (2014)[DOI]
63. Tanaka Y, "Radiotherapy for patients with unresectable advanced hepatocellular carcinoma with invasion to intrahepatic large vessels: efficacy and outcomes", J Gastroenterol Hepatol, 29, pp.352~357 (2014)[DOI]
64. 유정일, "Multicenter Validation Study of a Prognostic Index for Portal Vein Tumor Thrombosis in Hepatocellular Carcinoma", Cancer Research and Treatment, 46(4), pp.348~357 (2014), 대한암학회[DOI]
65. Duan F, "Trans-arterial chemoembolization and external beam radiation therapy for treatment of hepatocellular carcinoma with a tumor thrombus in the inferior vena cava and right atrium", Cancer Imaging, 15, pp.7~ (2015)[DOI]
66. Yu JI, "Radiotherapy as valid modality for hepatocellular carcinoma with portal vein tumor thrombosis", World J Gastroenterol, 22, pp.6851~6863 (2016)[DOI]
67. Im JH, "Radiotherapeutic strategies for hepatocellular carcinoma with portal vein tumour thrombosis in a hepatitis B endemic area", Liver Int, 37, pp.90~100 (2017)
68. Kim KM, "Reappraisal of repeated transarterial chemoembolization in the treatment of hepatocellular carcinoma with portal vein invasion", J Gastroenterol Hepatol, 24, pp.806~814 (2009)[DOI]
69. Li XL, "Efficacy of the treatment of transarterial chemoembolization combined with radiotherapy for hepatocellular carcinoma with portal vein tumor thrombus: A propensity score analysis", Hepatol Res, 46, pp.1088~1098 (2016)[DOI]
70. Lo CH, "Stereotactic ablative radiotherapy for unresectable hepatocellular carcinoma patients who failed or were unsuitable for transarterial chemoembolization", Eur J Gastroenterol Hepatol, 26, pp.345~352 (2014)[DOI]
71. Zhao Q, "Comparison of intraarterial chemoembolization with and without radiotherapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis: a meta-analysis", Ther Clin Risk Manag, 13, pp.21~31 (2017)
72. Kim KH, "Therapeutic benefit of radiotherapy in huge (<TEX>$\geq$<", TEX>10 cm) unresectable hepatocellular carcinoma, 2014, pp.34, 784~794
73. Koom WS, "Is local radiotherapy still valuable for patients with multiple intrahepatic hepatocellular carcinomas?", Int J Radiat Oncol Biol Phys, 77, pp.1433~1440 (2010)[DOI]
74. 윤홍인, "Clinical Benefit of Hepatic Arterial Infusion Concurrent Chemoradiotherapy in Locally Advanced Hepatocellular Carcinoma: A Propensity Score Matching Analysis", Cancer Research and Treatment, 48(1), pp.190~197 (2016), 대한암학회[DOI]
75. Lee HS, "Surgical resection after down-staging of locally advanced hepatocellular carcinoma by localized concurrent chemoradiotherapy", Ann Surg Oncol, 21, pp.3646~3653 (2014)[DOI]
76. 이익재, "Concurrent Chemoradiotherapy Shows Long-Term Survival after Conversion from Locally Advanced to Resectable Hepatocellular Carcinoma", Yonsei Medical Journal, 55(6), pp.1489~1497 (2014), 연세대학교의과대학[DOI]
77. Cheng SH, "A pilot study of three-dimensional conformal radiotherapy in unresectable hepatocellular carcinoma", J Gastroenterol Hepatol, 14, pp.1025~1033 (1999)[DOI]
78. Huang JF, "Incidence and clinical outcome of icteric type hepatocellular carcinoma", J Gastroenterol Hepatol, 17, pp.190~195 (2002)[DOI]
79. Emami B, "Tolerance of normal tissue to therapeutic irradiation", Int J Radiat Oncol Biol Phys, 21, pp.109~122 (1991)
80. Dawson LA, "Analysis of radiation-induced liver disease using the Lyman NTCP model", Int J Radiat Oncol Biol Phys, 53, pp.810~821 (2002)[DOI]
81. Seong J, "Lethal hepatic injury by combined treatment of radiation plus chemotherapy in rats with thioacetamide-induced liver cirrhosis", Int J Radiat Oncol Biol Phys, 57, pp.282~288 (2003)[DOI]
82. Dawson LA, "Partial volume tolerance of the liver to radiation", Semin Radiat Oncol, 15, pp.279~283 (2005)[DOI]
83. Kim TH, "Dose-volumetric parameters predicting radiation-induced hepatic toxicity in unresectable hepatocellular carcinoma patients treated with threedimensional conformal radiotherapy", Int J Radiat Oncol Biol Phys, 67, pp.225~231 (2007)[DOI]
84. Pan CC, "Radiation-associated liver injury", Int J Radiat Oncol Biol Phys, 76(3 Suppl), pp.S94~S100 (2010)[DOI]
85. Fukuda K, "Long-term outcomes of proton beam therapy in patients with previously untreated hepatocellular carcinoma", Cancer Sci, 108, pp.497~503 (2017)[DOI]
86. Mizumoto M, "Proton beam therapy for hepatocellular carcinoma: a comparison of three treatment protocols", Int J Radiat Oncol Biol Phys, 81, pp.1039~1045 (2011)[DOI]
87. Nakayama H, "Proton beam therapy for hepatocellular carcinoma: the University of Tsukuba experience", Cancer, 115, pp.5499~5506 (2009)[DOI]
88. Chiba T, "Proton beam therapy for hepatocellular carcinoma: a retrospective review of 162 patients", Clin Cancer Res, 11, pp.3799~3805 (2005)[DOI]
89. Bush DA, "The safety and efficacy of highdose proton beam radiotherapy for hepatocellular carcinoma: a phase 2 prospective trial", Cancer, 117, pp.3053~3059 (2011)[DOI]
90. Bush DA, "High-dose proton beam radiotherapy of hepatocellular carcinoma: preliminary results of a phase II trial", Gastroenterology, 127(5 Suppl 1), pp.S189~S193 (2004)[DOI]
91. Hong TS, "A prospective feasibility study of respiratory-gated proton beam therapy for liver tumors", Pract Radiat Oncol, 4, pp.316~322 (2014)[DOI]
92. Hong TS, "Multi-Institutional Phase II Study of High-Dose Hypofractionated Proton Beam Therapy in Patients With Localized, Unresectable Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma", J Clin Oncol, 34, pp.460~468 (2016)
93. 김태현, "Phase I Dose-Escalation Study of Proton Beam Therapy for Inoperable Hepatocellular Carcinoma", Cancer Research and Treatment, 47(1), pp.34~45 (2015), 대한암학회[DOI]
94. Kawashima M, "Phase II study of radiotherapy employing proton beam for hepatocellular carcinoma", J Clin Oncol, 23, pp.1839~1846 (2005)[DOI]
95. Fukumitsu N, "A prospective study of hypofractionated proton beam therapy for patients with hepatocellular carcinoma", Int J Radiat Oncol Biol Phys, 74, pp.831~836 (2009)[DOI]
96. Bush DA, "Randomized Clinical Trial Comparing Proton Beam Radiation Therapy with Transarterial Chemoembolization for Hepatocellular Carcinoma: Results of an Interim Analysis", Int J Radiat Oncol Biol Phys, 95, pp.477~482 (2016)[DOI]
97. Lee SU, "Effectiveness and safety of proton beam therapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis", Strahlenther Onkol, 190, pp.806~814 (2014)[DOI]
98. Sugahara S, "Proton-beam therapy for hepatocellular carcinoma associated with portal vein tumor thrombosis", Strahlenther Onkol, 185, pp.782~788 (2009)[DOI]
99. Hata M, "Proton beam therapy for hepatocellular carcinoma with portal vein tumor thrombus", Cancer, 104, pp.794~801 (2005)[DOI]
100. Hata M, "Proton beam therapy for aged patients with hepatocellular carcinoma", Int J Radiat Oncol Biol Phys, 69, pp.805~812 (2007)[DOI]
101. Mizumoto M, "Proton beam therapy for hepatocellular carcinoma adjacent to the porta hepatis", Int J Radiat Oncol Biol Phys, 71, pp.462~467 (2008)[DOI]
102. Sugahara S, "Proton beam therapy for large hepatocellular carcinoma", Int J Radiat Oncol Biol Phys, 76, pp.460~466 (2010)[DOI]
103. Shiba S, "Carbon ion radiotherapy for 80 years or older patients with hepatocellular carcinoma", BMC Cancer, 17, pp.721~ (2017)[DOI]
104. Hashimoto T, "Repeated proton beam therapy for hepatocellular carcinoma", Int J Radiat Oncol Biol Phys, 65, pp.196~202 (2006)[DOI]
105. Kawashima M, "Dose-volume histogram analysis of the safety of proton beam therapy for unresectable hepatocellular carcinoma", Int J Radiat Oncol Biol Phys, 79, pp.1479~1486 (2011)[DOI]
106. Kim DY, "Riskadapted simultaneous integrated boost-proton beam therapy (SIBPBT) for advanced hepatocellular carcinoma with tumour vascular thrombosis", Radiother Oncol, 122, pp.122~129 (2017)[DOI]
107. Kato H, "Results of the first prospective study of carbon ion radiotherapy for hepatocellular carcinoma with liver cirrhosis", Int J Radiat Oncol Biol Phys, 59, pp.1468~1476 (2004)[DOI]
108. Tsujii H, "Clinical Results of Carbon Ion Radiotherapy at NIRS", J Radiat Res, 48(Suppl A), pp.A1~A13 (2007)[DOI]
109. Imada H, "Comparison of efficacy and toxicity of short-course carbon ion radiotherapy for hepatocellular carcinoma depending on their proximity to the porta hepatis", Radiother Oncol, 96, pp.231~235 (2010)[DOI]
110. Kamada T, "Carbon ion radiotherapy in Japan: an assessment of 20 years of clinical experience", Lancet Oncol, 16, pp.e93~e100 (2015)[DOI]
111. Komatsu S, "Clinical results and risk factors of proton and carbon ion therapy for hepatocellular carcinoma", Cancer, 117, pp.4890~4904 (2011)[DOI]
112. Qi WX, "Charged particle therapy versus photon therapy for patients with hepatocellular carcinoma: a systematic review and meta-analysis", Radiother Oncol, 114, pp.289~295 (2015)[DOI]

관련 논문AI추천